Health

Haier Biomedical Achieves Double No. 1 Ranking in Euromonitor's Global Life Science Lab Equipment Report, Caps Three-Phase Global Expansion

QINGDAO, China, May 28, 2026 /PRNewswire/ -- Haier Biomedical (SHA: 688139) has been named the No. 1 Chinese brand in global life science laboratory equipment sales and No. 1 in overseas sales in the same category, according to 2025 data published by Euromonitor I...

2026-05-28 21:25 5118

NYSE Content Update: Hinge Health Shares Up 72% One Year from its IPO

NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, May 28, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins...

2026-05-28 21:14 7447

China-US Dual Filing Success: Porton Advanced's End-to-End Bacterial Vector CDMO Solution Accelerates NMPA Approval of Salvectors' Innovative Oncolytic Bacteria Therapy

CRANBURY, N.J. and SUZHOU, China, May 28, 2026 /PRNewswire/ -- Porton Advanced, a leading cell and gene therapy CDMO, recently announced its client Salvectors has received Investigational New Drug (IND) clearance for their proprietary and innovative oncolytic bacteria therapy, "YB1-X7 Injection,"...

2026-05-28 21:00 3371

POMDOCTOR LIMITED Announces Plan to Implement ADS Ratio Change

GUANGZHOU, China, May 28, 2026 /PRNewswire/ -- POMDOCTOR LIMITED (the "Company") (NASDAQ: POM), a leading online medical services platform for chronic diseases in China, today announced that it plans to change the ratio of its American Depositary Shares ("ADSs") to its Class A ordinary shares (th...

2026-05-28 20:00 5480

PeproMene Bio Announces Oral Presentation at EHA 2026 Highlighting Favorable Safety and Durable Responses with PMB-CT01 (BAFF-R CAR T-Cell Therapy) in B-cell Lymphomas, Including After Prior CD19 CAR T-Cell Failure

IRVINE, Calif., May 28, 2026 /PRNewswire/ -- PeproMene Bio, Inc. announced today that updated clinical data from its ongoing Phase 1 study evaluating PMB-CT01, an investigational B-cell activating factor receptor (BAFF-R)-targeted CAR T-cell therapy, have been selected for an oral presentation a...

2026-05-28 19:00 3124

REJUVANT OUTPERFORMS ALL TESTED SUPPLEMENTS, INCLUDING STANDARD AKG AND NAD+ IN LANDMARK AGING CELL STUDY

FERNANDINA BEACH, Fla., May 28, 2026 /PRNewswire/ -- Ponce De Leon Health (PDLH), a commercial stage longevity company focused on the extension of healthspan and the reduction of biologic age in humans and animals, today highlighted the publication of alandmark peer-reviewed study in the scientif...

2026-05-28 18:38 3122

DA NANG GLOBAL BUSINESS SUMMIT 2026 - SILVER GENERATION INNOVATION EDITION

POSITIONING DA NANG AS SOUTHEAST ASIA'S INTERNATIONAL HUB FOR THE SILVER ECONOMY & MEDICAL TOURISM DA NANG, Vietnam, May 28, 2026 /PRNewswire/ -- The 3rd Da Nang Global Business Summit 2026, themed"Silver Generation Innovation", concluded successfully on May 15 at Pullman Danang Beach Resort, br...

2026-05-28 17:48 3680

Asian Society of Cardiovascular Imaging and Philips sign MOU to strengthen imaging capabilities across Asia Pacific

New collaboration combines Philips' global imaging expertise with ASCI's clinical leadership and regional network to strengthen education and clinical excellence across the region SINGAPORE, May 28, 2026 /PRNewswire/ -- Royal Philips  (NYSE: PHG, AEX: PHIA), a ...

2026-05-28 17:34 6985

Aphranel® MagiCCrystal CaHA Filler Achieves EU MDR Certification as a Premium Regenerative Injectable

SHANGHAI, May 28, 2026 /PRNewswire/ -- Moyom Biotechnology announced that its premium regenerative aesthetics product, Aphranel® MagiCCrystal CaHA Filler officially achieved European Union Medical Device Regulation (EU MDR) certification on May 18, 2026, under the registered name "Calcium Hydrox...

2026-05-28 15:55 2771

Scientific forum in Singapore explores advanced PET/CT imaging

SINGAPORE, May 28, 2026 /PRNewswire/ -- Singapore General Hospital (SGH), a leading academic medical centre in Singapore, on May 21 hosted "Advancing Precision Imaging with Next Generation PET/CT," a scientific forum that brought together experts in molecular imaging, nuclear medicine, radiology,...

2026-05-28 14:16 3234

Leads Biolabs' PD-L1/4-1BB Bispecific Antibody Selected for Oral Presentation at WCLC 2026, Demonstrating Sustained Breakthrough Efficacy Signals in NSCLC

NANJING, China, May 28, 2026 /PRNewswire/ -- Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company," Stock Code: 9887.HK) today announced that the Phase II clinical study of its proprietary PD-L1/4-1BB bispecific antibody, Opamtistomig (LBL-024), in combination with chemotherapy for th...

2026-05-28 14:06 3628

Dymax Expands HLC Adhesive Portfolio with New Low Viscosity Medical Product

--New Adhesive Enables Reliable Bonding in Both Light and Shadowed Areas SINGAPORE, May 28, 2026 /PRNewswire/ -- Dymax, a global manufacturer of light-curing materials and equipment, today announced the release ofHLC-M-1004

2026-05-28 11:45 3468

From Hit Identification to Lead Optimization: Building Scientific Continuity in Early Drug Discovery

SHANGHAI, May 28, 2026 /PRNewswire/ -- On May 20, 2026, Viva Biotech hosted a V-Experts in Conversation webinar, "Managing Complexity in Modern Drug Discovery: A Practical Approach to Integrated Screening & Chemistry." Moderated by Victoria Ouroutzoglou, the roundtable featured Dr. Bing Xia, Vice...

2026-05-28 11:10 2666

Ribo Announces Phase 2 Clinical Trial Submission to EMA, Further Advancing siRNA Therapeutics in Thromboembolic Disease

SUZHOU, China and MÖLNDAL, Sweden, May 28, 2026 /PRNewswire/ -- Suzhou Ribo Life Science (stock code 06938.HK) and Ribocure Pharmaceuticals (together "Ribo") announce the submission of Phase 2 Clinical Trial Application (CTA) to the European Medicines Agency (EMA) for RBD1119, a siRNA based thera...

2026-05-28 10:43 3161

From Hit Identification to Lead Optimization: Building Scientific Continuity in Early Drug Discovery

SHANGHAI, May 28, 2026 /PRNewswire/ -- On May 20, 2026, Viva Biotech hosted a V-Experts in Conversation webinar, "Managing Complexity in Modern Drug Discovery: A Practical Approach to Integrated Screening & Chemistry." Moderated by Victoria Ouroutzoglou, the roundtable featured Dr. Bing Xia, Vice...

2026-05-28 10:37 2722

InterSystems and 59stVentures Advance AI-Ready Data Ecosystems Across ASEAN

Partnership enables interoperable data to accelerate scalable AI adoption across Southeast Asia SINGAPORE, May 28, 2026 /PRNewswire/ -- InterSystems , a creative data technology provider dedicated to helping customers solve critical scalability, interoperability,...

2026-05-28 09:00 3253

Antengene Receives CDE Endorsement to Initiate Pivotal Phase III CLINCH-3 Study of ATG-022 in CLDN18.2+ Advanced Gastric/GEJ Cancer

SHANGHAI and HONG KONG, May 28, 2026 /PRNewswire/ -- Antengene Corporation Limited  ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune dis...

2026-05-28 08:00 3093

FDA Breakthrough Device Designation Marks Major Milestone for Gene Solutions' SPOT-MAS 10 Multi-Cancer Screening Test

SINGAPORE, May 28, 2026 /PRNewswire/ -- Gene Solutions , a global biotechnology company advancing accessible genomic solutions for cancer detection and precision oncology, today announced that the U.S. Food and Drug Administration has grantedBreakthrough Device Design...

2026-05-28 06:00 3158

HEALEY ALS Platform Trial Regimen I expands to 240 participants

Highlights: * Neurizon announces an expansion to the size of Regimen I intended to support a larger and more informative dataset, with accelerated time to topline readout and no change in funding requirements * Increase in sample size driven by enrolment rate exceeding original expectations ...

2026-05-27 22:41 4555

Want to Stay Current on Latest in Cancer Prevention and Treatment? Free Service from NCCN Can Help

Weekly updates from the National Comprehensive Cancer Network share every time a change is made to evidence-based, expert consensus-driven guidelines for cancer prevention, screening, treatment, and supportive care. PLYMOUTH MEETING, Pa., May 27, 2026 /PRNewswire/ -- The National Comprehensive C...

2026-05-27 21:47 3578
1 ... 3456789 ... 874